A citation-based method for searching scientific literature

Jo-Anne E Manski-Nankervis, Sharmala Thuraisingam, Phyllis Lau, Irene Blackberry, Janet K Sluggett, Jenni Ilomaki, J Simon Bell, John Furler. Aust J Prim Health 2018
Times Cited: 6







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Screening for Chronic Kidney Disease.
Milda R Saunders, Adam Cifu, Monica Vela. JAMA 2015
22
33


Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications.
Rita Rachmani, Inna Slavachevski, Zohar Levi, Bat Zadok, Yoav Kedar, Mordchai Ravid. Eur J Intern Med 2002
86
16

Prescribing for older people with chronic renal impairment.
J Simon Bell, Natalie Blacker, V Tammy Leblanc, Christopher P Alderman, Adam Phillips, Debra Rowett, Simone Rossi, Oliver Frank, Alan Husband. Aust Fam Physician 2013
14
16

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
16

Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.
Matthew J Crowley, Clarissa J Diamantidis, Jennifer R McDuffie, C Blake Cameron, John W Stanifer, Clare K Mock, Xianwei Wang, Shuang Tang, Avishek Nagi, Andrzej S Kosinski,[...]. Ann Intern Med 2017
115
16

Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
Anna Solini, Giuseppe Penno, Enzo Bonora, Cecilia Fondelli, Emanuela Orsi, Roberto Trevisan, Monica Vedovato, Franco Cavalot, Mauro Cignarelli, Susanna Morano,[...]. J Am Geriatr Soc 2013
51
16

The use of oral antidiabetic agents in primary care.
Andrew John Weekes, Merlin C Thomas. Aust Fam Physician 2007
7
16

Metformin utilisation in Australian community and aged care settings.
Weiyi Huang, Gregory M Peterson, Syed Tabish R Zaidi, Ronald L Castelino. Diabetes Res Clin Pract 2015
3
33

A new blood glucose management algorithm for type 2 diabetes: a position statement of the Australian Diabetes Society.
Jenny E Gunton, N Wah Cheung, Timothy M E Davis, Sophia Zoungas, Stephen Colagiuri. Med J Aust 2014
37
16

Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
Silvio E Inzucchi, Kasia J Lipska, Helen Mayo, Clifford J Bailey, Darren K McGuire. JAMA 2014
310
16

The University of NSW electronic practice based research network: disease registers, data quality and utility.
J Taggart, S T Liaw, S Dennis, H Yu, A Rahimi, B Jalaludin, M Harris. Stud Health Technol Inform 2012
7
16

Insights into the management of chronic hepatitis C in primary care using MedicineInsight.
Kendal Chidwick, Debra Kiss, Rachel Gray, Jeannie Yoo, Michael Aufgang, Amany Zekry. Aust J Gen Pract 2018
2
50

The computerized medical record as a tool for clinical governance in Australian primary care.
Christopher Martin Pearce, Simon de Lusignan, Christine Phillips, Sally Hall, Joanne Travaglia. Interact J Med Res 2013
7
16

Epidemiology of chronic kidney disease in Australian general practice: National Prescribing Service MedicineWise MedicineInsight dataset.
Janette Radford, Alex Kitsos, Jim Stankovich, Ronald Castelino, Masuma Khanam, Matthew Jose, Gregory Peterson, Timothy Saunder, Barbara Wimmer, Tabish Razizaidi. Nephrology (Carlton) 2019
9
16


A survey of primary care doctors in ten countries shows progress in use of health information technology, less in other areas.
Cathy Schoen, Robin Osborn, David Squires, Michelle Doty, Petra Rasmussen, Roz Pierson, Sandra Applebaum. Health Aff (Millwood) 2012
156
16

Prescribing for people with type 2 diabetes and renal impairment in Australian general practice: A national cross sectional study.
Jo-Anne E Manski-Nankervis, Sharmala Thuraisingam, Janet K Sluggett, Phyllis Lau, Irene Blackberry, Jenni Ilomaki, John Furler, J Simon Bell. Prim Care Diabetes 2019
7
16



Monitoring cholesterol levels: measurement error or true change?
Paul P Glasziou, Les Irwig, Stephane Heritier, R John Simes, Andrew Tonkin. Ann Intern Med 2008
82
16

New diagnostic tests: more harm than good.
Bjørn Hofmann, H Gilbert Welch. BMJ 2017
29
16


Sensitivity and specificity of a monitoring test.
E R DeLong, W B Vernon, R R Bollinger. Biometrics 1985
34
16

Laboratory testing in newly treated elderly hypertensive patients without co-morbidities: a population-based cohort study.
Finlay Aleck McAlister, Karen Tu, Sumit R Majumdar, Rajdeep Padwal, Zhongliang Chen, Norman R C Campbell. Open Med 2007
9
16

Frequency monitoring of hemoglobin A1c, low-density lipoprotein, and urine protein laboratory testing: a College of American Pathologists Q-Probes study.
Peter L Perrotta, Ryan Jones, Rhona J Souers, Teresa P Darcy, Peter J Howanitz. Arch Pathol Lab Med 2014
2
50

Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study.
Andrew P McGovern, Benjamin Rusholme, Simon Jones, Jeremy N van Vlymen, Harshana Liyanage, Hugh Gallagher, Charles R V Tomson, Kamlesh Khunti, Kevin Harris, Simon de Lusignan. BMC Nephrol 2013
12
16



The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
Keyur B Shah, Krishnamurti Rao, Robert Sawyer, Stephen S Gottlieb. J Am Coll Cardiol 2005
96
16

Evaluation of Parotid Salivary Glucose Level for Clinical Diagnosis and Monitoring Type 2 Diabetes Mellitus Patients.
Beibei Wang, Juan Du, Zhao Zhu, Zhihong Ma, Songlin Wang, Zhaochen Shan. Biomed Res Int 2017
7
16

Variation in test ordering behaviour of GPs: professional or context-related factors?
Wim H J M Verstappen, Gerben ter Riet, Willy I Dubois, Ron Winkens, Richard P T M Grol, Trudy van der Weijden. Fam Pract 2004
46
16



Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.
T Yamanouchi, N Ogata, T Tagaya, T Kawasaki, N Sekino, H Funato, L Akaoka, H Miyashita. Lancet 1996
121
16

[Monitoring kidney function in patients with essential hypertension treated with enalapril].
K Orzechowska-Juzwenko, E Jaźwińska-Tarnawska, M L Hurkacz, K Loboz-Grudzień. Pol Arch Med Wewn 1997
1
100

Health economic modelling of the cost-effectiveness of microalbuminuria screening in Switzerland.
Reto Kessler, Gérald Keusch, Thomas D Szucs, John S Wittenborn, Thomas J Hoerger, Urs Brügger, Simon Wieser. Swiss Med Wkly 2012
9
16



Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
16

Factors associated with ordering laboratory monitoring of high-risk medications.
Shira H Fischer, Jennifer Tjia, George Reed, Daniel Peterson, Jerry H Gurwitz, Terry S Field. J Gen Intern Med 2014
7
16

[Spending with unnecessary complementary tests for hypertension and diabetes in health services].
Thiago Roberto Castellane Arena, Marli de Carvalho Jericó, Liliana Cristina de Castro, Valéria Castilhod, Antonio Fernandes Costa Lima. Rev Gaucha Enferm 2014
1
100


Variations in lipid screening frequency in family medicine patients with cardiovascular risk factors.
Yusuf C Doganer, James E Rohrer, Kurt B Angstman, Stephen P Merry, Jacob L Erickson. J Eval Clin Pract 2015
2
50


Normal diagnostic test results do not reassure patients.
Keith J Petrie, Rebekah Sherriff. Evid Based Med 2014
8
16



Which lipid measurement should we monitor? An analysis of the LIPID study.
Paul P Glasziou, Les Irwig, Adrienne C Kirby, Andrew M Tonkin, R John Simes. BMJ Open 2014
7
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.